Ashvattha unit Orpheris enrols first patients in Phase II PRANA trial
PRANA is a double-blind, placebo-controlled Phase II clinical trial that evaluates the efficacy of OP-101 in patients with severe Covid-19. Credit: Ri Butov from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more